Gilead cystic fibrosis drug fares well in trial
Tue, 19 Dec 2006 10:31 PM EST
... NEW YORK (Reuters) - Gilead Sciences Inc on Tuesday said a preliminary analysis showed that its experimental inhaled treatment for cystic fibrosis met its primary effectiveness goal in a late-stage study, without serious side effects. ...
Related Topics
- Cystic Fibrosis
- Clinical Trials
- Pulmonary Fibrosis
- Cystic Hygroma
- Drug Safety
- Prescription Drugs
- Tarceva
- Drug Side Effects
- Drug Abuse
- Drug Information
- Prescription Drug Abuse
- Prescription Drugs Abuse
- Fibrosis
- Mastitis
- Interstitial pulmonary fibrosis
- Prenatal Testing
- Bevacizumab Injection
- Genes and Gene Therapy
- Club Drugs
- Acne

Not Signed In -


